Scopolamine Patch
Product Images NDC 50090-5349

8 FDA label images from A-s Medication Solutions · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Scopolamine (NDC 50090-5349). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Scopolamine Structural Formula (Image 02)

Scopolamine Structural Formula (Image 02)
Chemical structure diagram of scopolamine, the active ingredient in the Scopolamine 1 mg/3d transdermal patch by A-S Medication Solutions. The diagram shows the molecular arrangement of atoms and bonds characteristic of scopolamine.*
FDA Label Image

Cross Section Of The System (Image 03)

Cross Section Of The System (Image 03)
An illustration diagram showing the layered structure of a Scopolamine transdermal patch. The layers from top to bottom are labeled as Backing Layer, Solid Matrix Drug Reservoir, Membrane, Adhesive Formulation, and Protective Release Liner, depicting the components of the patch delivery system.*
FDA Label Image

Instructions For Use Figure 1 (Image 04)

Instructions For Use Figure 1 (Image 04)
An illustration depicting a transdermal patch for Scopolamine showing its layers: a clear disposable release liner, an adhesive surface, and a peach backing membrane imprinted with "Scopolamine 1 mg / 3 days."*
FDA Label Image

Instructions For Use Figure 2 (Image 05)

Instructions For Use Figure 2 (Image 05)
An instructional illustration showing a tear pouch with a dashed line indicating where to open it. The image is labeled 'Tear Pouch Open Along Dashed Line,' likely demonstrating how to open the pouch containing the Scopolamine transdermal patch.*
FDA Label Image

Instructions For Use Figure 3 (Image 06)

Instructions For Use Figure 3 (Image 06)
An instructional illustration showing two hands peeling apart the backing of a patch, likely demonstrating how to open or prepare a transdermal patch for application.*
FDA Label Image

Instructions For Use Figure 4 (Image 07)

Instructions For Use Figure 4 (Image 07)
Illustration showing the application of a Scopolamine transdermal patch. The patch is depicted as an imprinted, peach-colored transdermal system with an adhesive surface, covered by a clear, disposable release liner being peeled off prior to use.*
FDA Label Image

Instructions For Use Figure 5 (Image 08)

Instructions For Use Figure 5 (Image 08)
Illustration showing a side profile of a person's head with an imprinted, peach-colored transdermal system applied behind the ear, depicting placement of the Scopolamine 1 mg/3d transdermal patch.*
FDA Label Image

Label Image (Lbl500905349)

Label Image (Lbl500905349)
Scopolamine 1 mg/3 days transdermal patch label from A-S Medication Solutions. The label includes storage instructions to keep the patch at 68 to 77 degrees Fahrenheit and specifies that each transdermal system contains 1.5 mg scopolamine base formulated to deliver approximately 1 mg over 3 days. The label also shows the NDC 50090-5349 and directs users to see the package insert for dosing information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.